Variant report

Variant	nsv1874
Chromosome Location	chr16:74069161-74114200
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:24)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:24 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:74069423..74070583-chr16:74308622..74309589,7	MCF-7	breast:
2	chr16:74097985..74098900-chr16:74260227..74261150,3	MCF-7	breast:
3	chr16:74070917..74073817-chr16:74078438..74081028,2	K562	blood:
4	chr16:74076253..74078540-chr16:74083020..74085700,2	K562	blood:
5	chr16:74072390..74076455-chr16:74084925..74088103,4	MCF-7	breast:
6	chr15:81148713..81149213-chr16:74074311..74075148,2	MCF-7	breast:
7	chr16:74104331..74106027-chr16:74106747..74108589,2	MCF-7	breast:
8	chr16:74098007..74098865-chr16:74308598..74309538,5	MCF-7	breast:
9	chr16:74079958..74082316-chr16:74083747..74086462,2	MCF-7	breast:
10	chr16:74079958..74082316-chr16:74083747..74086462,2	MCF-7	breast:
11	chr16:74070917..74074428-chr16:74076100..74081028,4	K562	blood:
12	chr16:74076253..74078540-chr16:74083020..74085700,2	K562	blood:
13	chr16:73990291..73990950-chr16:74068417..74069327,2	MCF-7	breast:
14	chr16:74069689..74070330-chr16:74308730..74309631,3	MCF-7	breast:
15	chr16:74098142..74098838-chr16:74260245..74261120,2	MCF-7	breast:
16	chr16:74069417..74070349-chr16:74141043..74142294,9	MCF-7	breast:
17	chr16:74069299..74070320-chr16:74260061..74261105,4	MCF-7	breast:
18	chr16:74072390..74076455-chr16:74084925..74088103,4	MCF-7	breast:
19	chr16:74104331..74106027-chr16:74106747..74108589,2	MCF-7	breast:
20	chr16:74070917..74074428-chr16:74076100..74081028,4	K562	blood:
21	chr16:73598919..73599801-chr16:74068414..74069364,3	MCF-7	breast:
22	chr16:74070917..74073817-chr16:74078438..74081028,2	K562	blood:
23	chr16:74097992..74098897-chr16:74141463..74142359,4	MCF-7	breast:
24	chr16:74068477..74070420-chr16:74260250..74261186,10	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CLEC18B-6	chr16:74106215-74106486	expReg_chr16_7681_-
2	lnc-CLEC18B-3	chr16:74088050-74088504	ENSG00000261404.1

No data

Extended variants
information (count: 1929 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:1929 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs563240952	chr16:74069174-74069175	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs552461820	chr16:74069194-74069195	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs529032658	chr16:74069223-74069224	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs548898020	chr16:74069228-74069229	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs60043289	chr16:74069267-74069268	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs570307817	chr16:74069348-74069349	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs528366336	chr16:74069368-74069369	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs539275586	chr16:74069465-74069466	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs151220498	chr16:74069476-74069477	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs140465749	chr16:74069531-74069532	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs372797941	chr16:74069532-74069533	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs67406934	chr16:74069595-74069596	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
13	rs567644100	chr16:74069601-74069602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs369575485	chr16:74069612-74069613	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs569579759	chr16:74069632-74069633	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs189343799	chr16:74069661-74069662	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs573125311	chr16:74069672-74069673	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs548872872	chr16:74069682-74069683	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs568643612	chr16:74069684-74069685	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs11316064	chr16:74069685-74069686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs59653279	chr16:74069699-74069700	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs398029910	chr16:74069700-74069701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs35855360	chr16:74069713-74069714	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs538914850	chr16:74069721-74069722	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs115552034	chr16:74069790-74069791	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs551693875	chr16:74069793-74069794	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs181798170	chr16:74069799-74069800	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs185937602	chr16:74069814-74069815	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs555050686	chr16:74069883-74069884	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs563337245	chr16:74069885-74069886	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs190449194	chr16:74069922-74069923	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs183203829	chr16:74069926-74069927	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs555427540	chr16:74069940-74069941	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs559248494	chr16:74069986-74069987	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs186467415	chr16:74069995-74069996	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs377373835	chr16:74070060-74070061	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs11316065	chr16:74070061-74070062	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs397855940	chr16:74070074-74070075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs33961645	chr16:74070075-74070076	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs551652910	chr16:74070080-74070081	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs191009506	chr16:74070085-74070086	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs530865150	chr16:74070165-74070166	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs550681902	chr16:74070207-74070208	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs567682012	chr16:74070252-74070253	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs538519205	chr16:74070269-74070270	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs539503722	chr16:74070270-74070271	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs151015538	chr16:74070301-74070302	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs182856620	chr16:74070321-74070322	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs547088951	chr16:74070323-74070324	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs574879381	chr16:74070346-74070347	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Hepatocellular carcinoma	16750200	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21806811	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21509527	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD
Cancer	17160897	CNVD
Breast cancer	20409316	CNVD
Myelofibrosis	22110671	CNVD
Poland''s syndrome	22110015	CNVD
Neuroblastoma	21899760	CNVD
Liver carcinoma	19366792	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Prostate cancer	19156837	CNVD
Acute myeloid leukemia	17377590	CNVD

Chromatin state (count:121 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:74062600-74071400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr16:74063600-74071200	Enhancers	iPS-15b Cell Line	embryonic stem cell
3	chr16:74063800-74071200	Enhancers	HUES48 Cell Line	embryonic stem cell
4	chr16:74063800-74071400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
5	chr16:74064400-74086400	Weak transcription	Thymus	Thymus
6	chr16:74066600-74071000	Weak transcription	H9 Cell Line	embryonic stem cell
7	chr16:74067000-74071200	Enhancers	HUES64 Cell Line	embryonic stem cell
8	chr16:74067200-74071400	Enhancers	iPS-18 Cell Line	embryonic stem cell
9	chr16:74067200-74071400	Enhancers	iPS-20b Cell Line	embryonic stem cell
10	chr16:74067600-74069200	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr16:74068000-74071200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr16:74068400-74069200	Weak transcription	Fetal Thymus	thymus
13	chr16:74068400-74069600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr16:74068400-74069600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
15	chr16:74068600-74069200	Enhancers	Brain Anterior Caudate	brain
16	chr16:74068600-74069200	Enhancers	Fetal Lung	lung
17	chr16:74068600-74069600	Enhancers	H1 Cell Line	embryonic stem cell
18	chr16:74068600-74071800	Enhancers	Dnd41	blood
19	chr16:74069000-74070200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr16:74069200-74070200	Weak transcription	HUES6 Cell Line	embryonic stem cell
21	chr16:74069200-74071400	Enhancers	Fetal Thymus	thymus
22	chr16:74069600-74070200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr16:74069600-74070400	Weak transcription	H1 Cell Line	embryonic stem cell
24	chr16:74069600-74071200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
25	chr16:74069800-74070000	Enhancers	Primary hematopoietic stem cells short term culture	blood
26	chr16:74070000-74070200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
27	chr16:74070200-74071200	Enhancers	HUES6 Cell Line	embryonic stem cell
28	chr16:74070200-74071200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr16:74070400-74070600	Enhancers	ES-I3 Cell Line	embryonic stem cell
30	chr16:74070400-74071200	Enhancers	H1 Cell Line	embryonic stem cell
31	chr16:74071000-74071200	Enhancers	H9 Cell Line	embryonic stem cell
32	chr16:74071000-74071400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
33	chr16:74071200-74072600	Weak transcription	H9 Cell Line	embryonic stem cell
34	chr16:74071200-74073400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
35	chr16:74071400-74077000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
36	chr16:74073400-74074000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
37	chr16:74074400-74074600	Enhancers	H9 Cell Line	embryonic stem cell
38	chr16:74077000-74077200	Enhancers	iPS-18 Cell Line	embryonic stem cell
39	chr16:74077200-74077800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
40	chr16:74077800-74078000	Enhancers	iPS-18 Cell Line	embryonic stem cell
41	chr16:74079600-74080600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
42	chr16:74079800-74080200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr16:74080200-74080800	Enhancers	Brain Germinal Matrix	brain
44	chr16:74080400-74080800	Enhancers	Brain Anterior Caudate	brain
45	chr16:74080600-74081000	Enhancers	Brain Substantia Nigra	brain
46	chr16:74083000-74083400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr16:74085200-74087200	Enhancers	Dnd41	blood
48	chr16:74085800-74087000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr16:74085800-74088600	Enhancers	Primary hematopoietic stem cells	blood
50	chr16:74085800-74088600	Enhancers	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links